VX1 vs IM007

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

VX1 is an AI software designed to assist cardiac electrophysiologists in real-time during ablation procedures by identifying dispersed electrograms. In contrast, IM007 is a cloud-based platform for remote cardiac monitoring, aggregating data from implantable devices to streamline workflows and manage alerts. While both are FDA-cleared AI tools in cardiology, VX1 focuses on intra-procedural guidance, whereas IM007 optimizes ongoing patient management and remote monitoring.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Frequently Asked Questions

VX1 is designed to assist cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. IM007 is an AI-powered, cloud-based platform for remote cardiac monitoring, aggregating data from all cardiac implantable electronic devices (CIEDs) to streamline workflows and manage heart failure.
VX1 is a software integrated with existing electrophysiology (EP) lab mapping and recording systems. IM007 is a cloud-based SaaS platform that offers unified device data aggregation from various CIED manufacturers and has EHR integration capabilities through a bidirectional API and integration framework.
VX1 analyzes 3D anatomical and electrical maps of human atria to identify dispersed electrograms and provides cycle length estimation. IM007 aggregates data from cardiac implantable electronic devices (CIEDs) and uses AI for ILR ECG data analysis and predictive AI for heart failure hospitalization risk.
VX1 is designed to reduce inter-operator variability and standardize outcomes during AFib and atrial tachycardia ablation procedures. IM007 aims to streamline workflows, reduce false alerts (e.g., 79% for ILR ECG Analyzer, 85% for AF alerts), and improve patient outcomes in remote cardiac monitoring and heart failure management.

Backers

Who funded each tool's parent company.

IM007

AI Tool Finder
AI-powered search. Results may not be comprehensive.